[Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsmedizin Mainz.
H
H
Lang
J
J
Ricke
J
J
Schlaak
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001918:Brachytherapy; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D016031:Liver Transplantation; D019520:Living Donors; D009367:Neoplasm Staging; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives; D010671:Phenylurea Compounds / Q000008:administration & dosage; D000077157:Sorafenib; D013813:Therapy, Computer-Assisted
D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib